Inspire Medical Systems (STU:2DR) Forward Dividend Yield %: 0.00% (As of Jun. 27, 2026)


STU:2DR Inspire Medical Systems Inc STU:2DR
55 GF Score
Price €40.00
GF Value €190.55
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Forward Dividend Yield %?

Inspire Medical Systems STU:2DR +4.17% 55 Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus rates STU:2DR with a GF Score™ of 55/100 and a GF Value™ of €190.55 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Inspire Medical Systems ranks worse than 316455.38% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of Inspire Medical Systems is 0.00%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of Inspire Medical Systems is 0.00%.

STU:2DR's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.09
* Ranked among companies with meaningful Forward Dividend Yield % only.

Inspire Medical Systems's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Inspire Medical Systems  (STU:2DR) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Inspire Medical Systems Forward Dividend Yield % Related Terms


STU:2DR vs BFLY, ATEC, TNDM: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Inspire Medical Systems's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Forward Dividend Yield % falls into.


STU:2DR
55GF Score
Inspire Medical Systems Inc STU:2DR
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Inspire Medical Systems (STU:2DR) has a Forward Dividend Yield % of 0.00% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Inspire Medical Systems' Forward Dividend Yield % too high?
Inspire Medical Systems' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Inspire Medical Systems ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Forward Dividend Yield % compare to BFLY and ATEC?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #999999 out of 316 companies for Forward Dividend Yield %. This places Inspire Medical Systems in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Inspire Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €190.55, compared to a current price of €40.00 — trading 79% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Inspire Medical Systems' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €40.00 is trading 79% below its estimated GF Value™ of €190.55. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: €190.55 vs. price of €40.00 (79% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
55GF Score

Get the complete analysis for STU:2DR

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.00
Price
€190.55
GF Value